A notable advancement in blood sugar treatment is emerging with the release of tirzepatide at a dosage of 45mg. This innovative version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://haaristatb637977.wikigiogio.com/2300081/groundbreaking_approach_tirzepatide_45mg_for_blood_sugar_control